Investment Q&A

Q: I sold a put, $44.00 strike price, expires April 16, 2021. Was wondering how WFT takeover will affect my option?

Q: What do you think of Metro now and what do you think about the results just announced?

Q: I’m looking for a low fee ETF for emerging markets, but which excludes China. Can you offer any suggestions? Thanks!

Q: What can we expect from real matters.Thanks

Q: I own a full position in FTNT and in RPD in a registered account. The holding is for 10 years +++ Would you be inclined to switch one of the two for CRWD , which one and why? There would be no fees associate to the trade (no tax implication and trading fees are not significative relative to the size of the position)
if not, why?

Q: What is your opinion of this ETF is the hype of its expected growth over rated? Cheers

Q: Guest on BNN yesterday did not having anything nice to day about KXS while 5iresearch likes it a lot. Would it be a good time to buy back shares I sold o er $200, or buy GSY which I have hesitated for a long time?

Q: Would like your opinion for 3 Can and 3 US value stocks with a decent dividend which might have some growth in the next 3 years.
Thanks
Jeff

Q: With the increase in price of KXS,DSG, SHOP, REAL and LSPD I now have a total of 23% of my portfolio in these shares. I have taken profits and reduced my position each of them. The only concerns I have going forward is with KXS and DSG. Ross Healy on BNN did not have a very Rosie picture for KXS. I know that different views is what makes a market. You continue to be much more positive on KXS and continue to recommend it. DSG andKXS are somewhat similar. I respect your opinion, would you recommend selling either one? If so which? I view many of these guest as having a person interest in recommendations. I always take them with a grain of salt. I have seen this in my previous life while working for a major investment firm.

Q: Hi guys

I have been looking at Jamieson for a while as I like their products. Just wondering the amount of insider ownership is, what your opinion of their management team is, and at this price ($34.81) point, given their expected growth, whether you see this as a decent entry point.

Thanks so much

Stuart

Q: Peter was on BNN and recommended above two stocks. I am planning to invest these two stocks. Should I step in with full position at this price?

Thanks,

Q: This question is about MTRX or Loop Insights on the TSXV. It doesn't seem to be in your system when I entered the ticker.

Loop Insights is getting a lot of chatter amongst the self-directed crowd on Reddit and the stock price is rocketing up accordingly.

Is this company legitimate? Is there great potential here? Or is the stock price a pump?

Cam.

Q: Hello Peter,
Can you comment on curaleaf's earnings? This company has been doing well but it looks like the market did not like its current earnings yet the company is growing nicely. Also, why would a company remove the current CEO that has done quite well for the company? Any reason for the other three stocks: jwel well, and doc to be taking a hit. Is this just short term sector rotation due to the vaccine announcement and if so, is it better just to hold these for longer timeframe? Thanks very much.

Q: Please comment on BOS latest quarter results and whether you think it is currently a good investment or if not, what you would prefer instead (in the same sector). Thanks!

Q: Can you please comment on Gran Colombia’s latest qtr and dividend announcement. I find the stock quite cheap. What is your take? Thanks

Q: Hello Folks:
As the Covid situation has hastened the move to online shopping, some brick and mortar stores are going to have a much brighter future than others. Businesses such as Walmart and Best Buy appear to be having more success than others. I would appreciate your suggestions on choosing companies which have the brightest future integrating these two systems.
Thank you again for your great service!
brian

Q: Should I double my position in WCP to cut my losses

Q: Hello,

What would be your favorite healthcare stocks in the US other then technology/healthcare stocks

Thank you

Q: I have owned AYX for a year - its been an exciting ride with the stock peaking 66% higher than its current price (I did not sell) I find myself back to where I started. In your view, how much of this volatility is due to management erring on the side of conservative guidance and thus tempering market enthusiasm and how much is a reevaluation by the street that perhaps there are better growth opportunities out there. Since it is part of my US High Growth portfolio, I am perfectly fine with the volatility if it is still on track. My question is, if this were in your US High Growth portfolio would you be keeping it or replacing it with a higher conviction name. If your answer is to replace it, what would be your top 2 names.

Many Thanks
Scott

Q: I have been holding BIIB for a couple of years on hopes (I know, that is not an investment strategy) that their alzheimer drug would be approved. It has come close a few times and the stock has reacted very favourably only to fall short of approval and fall back in price. Do you believe that the recent setback will make BIIB dead money for the foreseeable future and its best to move on or is it too cheap and compelling a story to sell now? If BIIB was part of your US Growth portfolio would you keep it or sell in favour of a better growth stock. If your decision would be to sell, what would be the top 2 names for replacement with no regard to sector.

Thanks
Scott